Cargando…
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
Here, we report on a phase IIa study to determine the intubation rate, survival, viral clearance, and development of endogenous Abs in patients with COVID-19 pneumonia treated with convalescent plasma (CCP) containing high levels of neutralizing anti–SARS-CoV-2 Abs. Radiographic and laboratory evalu...
Ejemplares similares
-
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
por: Fanning, Stacey L., et al.
Publicado: (2021) -
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
por: Ip, Andrew, et al.
Publicado: (2020) -
Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients
por: Baker, Melissa, et al.
Publicado: (2021) -
Case Report: Non-infectious causes of palmoplantar rashes, what to consider
por: Advani, Rashmi, et al.
Publicado: (2018) -
Case Report: Hepatopulmonary syndrome as the first clinical manifestation of cirrhosis in a patient with underlying chronic lung disease
por: Murphy, Charles, et al.
Publicado: (2019)